Table 3.
Characteristics associated with delay ≥90 days in receipt of definitive therapy (RC or neoadjuvant chemotherapy)
| Characteristic | aOR [CI] | P Value | Characteristic | aOR [CI] | P Value |
|---|---|---|---|---|---|
| Care Transition | 2.0 [1.8–2.2] | <0.001 | Hospital Category | ||
| Age (years) | Community | 1.0 | |||
| ≤50 | 1.0 | 0.4851 | Comp community | 1.01 [0.86–1.18] | 0.9437 |
| 51 to 60 | 1.07 [0.89–1.29] | 0.4851 | Academic | 1.20 [1.00–1.45] | 0.0536 |
| 61 to 70 | 1.13 [0.95–1.35] | 0.1734 | Payor Group | ||
| ≥71 | 1.19 [1.00–1.43] | 0.0563 | Private/HMO | 1.0 | |
| Gender | Medicaid | 1.37 [1.13–1.66] | 0.0014 | ||
| Male | 1.11 [1.07–1.16] | <.0001 | Medicare | 1.20 [1.08–1.34] | 0.0012 |
| Race | None/Unknown | 1.28 [1.07–1.54] | 0.0077 | ||
| White | 1.0 | Geographic Location | |||
| AA | 1.48 [1.26–1.73] | <.0001 | Rural | 1.0 | |
| Other | 0.82 [0.63–1.06] | 0.1367 | Suburban | 1.00 [0.89–1.12] | 0.9773 |
| Charlson-Deyo Score | Small metropolitan | 1.01 [0.92–1.10] | 0.8749 | ||
| 0 | 1.0 | Large metropolitan | 0.99 [0.89–1.10] | 0.8256 | |
| 1 | 1.09 [1.00–1.19] | 0.0599 | Unknown | Ref | |
| ≥2 | 1.25 [1.08–1.45] | 0.0034 | Facility Location | ||
| Analytic Stage | Northeast | 1.52 [1.25–1.85] | <.0001 | ||
| II | 1.02 [0.96–1.07] | 0.5819 | Atlantic | 1.36 [1.20–1.54] | <.0001 |
| III | 1.02 [0.96–1.07] | 0.5298 | Southeast | 1.00 [0.88–1.12] | 0.948 |
| IV | 1.0 | Great Lakes | 0.86 [0.76–0.97] | 0.018 | |
| Tumor Grade | South | 0.72 [0.59–0.87] | 0.0008 | ||
| Low Grade (1/2) | 1.05 [0.93–1.20] | 0.4101 | Midwest | 0.80 [0.64–0.99] | 0.0432 |
| High Grade (3/4) | 0.95 [0.87–1.04] | 0.2595 | West | 0.71 [0.59–0.87] | 0.0006 |
| Unknown | 1.0 | Mountain | 1.01 [0.80–1.28] | 0.9195 | |
| Median Income | Pacific | 1.0 | |||
| <$30K | 1.0 | Year of Diagnosis | |||
| $30–34.9K | 0.93 [0.80–1.09] | 0.3853 | 2003 | 0.88 [0.78–0.99] | 0.0307 |
| $35–45.9K | 1.07 [0.92–1.24] | 0.3651 | 2004 | 0.91 [0.81–1.02] | 0.09 |
| ≥$46K | 1.11 [0.94–1.32] | 0.2225 | 2005 | 1.04 [0.95–1.15] | 0.4153 |
| Unknown | 0.81 [0.57–1.14] | 0.2204 | 2006 | 1.02 [0.92–1.12] | 0.7672 |
| Percent less than high school education | 2007 | 1.09 [0.96–1.23] | 0.1974 | ||
| ≥29% | 1.0 | 2008 | 1.07 [0.97–1.18] | 0.162 | |
| 20–28.9% | 0.94 [0.83–1.07] | 0.3262 | 2009 | 1.08 [0.97–1.21] | 0.1434 |
| 14–19.9% | 0.84 [0.73–0.96] | 0.0119 | 2010 | 1.0 | |
| <14% | 0.69 [0.59–0.82] | <.0001 | Volume (Tertiles) | ||
| Unknown | 1.0 [1.0–1.0] | 0.546 | T1 | 1.0 | |
| T2 | 0.86 [0.75–0.99] | 0.0369 | |||
| T3 | 0.87 [0.74–1.02] | 0.0939 | |||
Controlling for age, gender, race, Charlson-Deyo score, analytic stage, tumor grade, hospital category, payor group, geographic location, median income, proportion with less than high school education, year, region